These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33128033)

  • 41. Anaphylactic and non-anaphylactic murine IgG1 differ in their ability to bind to mast cells: relevance of proper glycosylation of the molecule.
    Faquim-Mauro EL; Jacysyn JF; Macedo MS
    Immunobiology; 2003; 207(3):169-77. PubMed ID: 12777058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of hyperglycosylated human chorionic gonadotropin produced by malignant gestational trophoblastic neoplasias and male germ cell tumors using a lectin-based immunoassay and surface plasmon resonance.
    Kelly LS; Birken S; Puett D
    Mol Cell Endocrinol; 2007 Jan; 260-262():33-9. PubMed ID: 17081681
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Avidity confers FcγR binding and immune effector function to aglycosylated immunoglobulin G1.
    Nesspor TC; Raju TS; Chin CN; Vafa O; Brezski RJ
    J Mol Recognit; 2012 Mar; 25(3):147-54. PubMed ID: 22407978
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acridinium esters as high-specific-activity labels in immunoassay.
    Weeks I; Beheshti I; McCapra F; Campbell AK; Woodhead JS
    Clin Chem; 1983 Aug; 29(8):1474-9. PubMed ID: 6191885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody internalization after cell surface antigen binding is critical for immunotoxin development.
    Kuo SR; Alfano RW; Frankel AE; Liu JS
    Bioconjug Chem; 2009 Oct; 20(10):1975-82. PubMed ID: 19785403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epitope characterization of pre-existing and developing antibodies to an aglycosylated monoclonal antibody therapeutic of G1m17,1 allotype.
    Tatarewicz SM; Juan G; Swanson SJ; Moxness MS
    J Immunol Methods; 2012 Aug; 382(1-2):93-100. PubMed ID: 22609464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms.
    Wada R; Matsui M; Kawasaki N
    MAbs; 2019; 11(2):350-372. PubMed ID: 30466347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Site-specific glycosylation of an aglycosylated human IgG1-Fc antibody protein generates neoglycoproteins with enhanced function.
    Watt GM; Lund J; Levens M; Kolli VS; Jefferis R; Boons GJ
    Chem Biol; 2003 Sep; 10(9):807-14. PubMed ID: 14522051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
    Wright A; Morrison SL
    J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of Drug Conjugation on Thermal and Metabolic Stabilities of Aglycosylated and
    Yamazoe S; Kotapati S; Hogan JM; West SM; Deng XA; Diong SJ; Arbanas J; Nguyen TA; Jashnani A; Gupta D; Rajpal A; Dollinger G; Strop P
    Bioconjug Chem; 2022 Apr; 33(4):576-585. PubMed ID: 35344340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
    Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
    Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity.
    Finlay JA; Evans CL; Day JR; Payne JK; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Wolfert RL; Rittenhouse HG
    Urology; 1998 May; 51(5):804-9. PubMed ID: 9610595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results.
    Gidwani K; Kekki H; Terävä J; Soukka T; Sundfeldt K; Pettersson K
    Mol Aspects Med; 2020 Apr; 72():100831. PubMed ID: 31787337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural differences between glycosylated, disulfide-linked heterodimeric Knob-into-Hole Fc fragment and its homodimeric Knob-Knob and Hole-Hole side products.
    Kuglstatter A; Stihle M; Neumann C; Müller C; Schaefer W; Klein C; Benz J;
    Protein Eng Des Sel; 2017 Sep; 30(9):649-656. PubMed ID: 28985438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Particle concentration fluorescence immunoassay (PCFIA): a new, rapid immunoassay technique with high sensitivity.
    Jolley ME; Wang CH; Ekenberg SJ; Zuelke MS; Kelso DM
    J Immunol Methods; 1984 Feb; 67(1):21-35. PubMed ID: 6366066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in cell surface glycosylation in alpha1,3-galactosyltransferase knockout and alpha1,2-fucosyltransferase transgenic mice.
    Shinkel TA; Chen CG; Salvaris E; Henion TR; Barlow H; Galili U; Pearse MJ; d'Apice AJ
    Transplantation; 1997 Jul; 64(2):197-204. PubMed ID: 9256173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal Antibodies Against Human Cardiac Troponin I for Immunoassays II.
    Lee G; Liu S
    Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):169-73. PubMed ID: 26090594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation.
    Lund J; Tanaka T; Takahashi N; Sarmay G; Arata Y; Jefferis R
    Mol Immunol; 1990 Nov; 27(11):1145-53. PubMed ID: 2174119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of VK framework-1 glycosylation on the binding affinity of lymphoma-specific murine and chimeric LL2 antibodies and its potential use as a novel conjugation site.
    Leung SO; Dion AS; Pellegrini MC; Losman MJ; Grebenau RC; Goldenberg DM; Hansen HJ
    Int J Cancer; 1995 Feb; 60(4):534-8. PubMed ID: 7829269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Restricted processing of CD16a/Fc γ receptor IIIa
    Patel KR; Roberts JT; Subedi GP; Barb AW
    J Biol Chem; 2018 Mar; 293(10):3477-3489. PubMed ID: 29330305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.